Navigation Links
Parenteral Depots Offer $8 Billion of Reformulation Opportunities and a Strong Competitive Edge in Crowded Pharmaceutical Space
Date:2/14/2011

impressive development effort under way for risperidone, octreotide, triptorelin, goserelin, leuprorelin, lanreotide, that could position Bharat as a global leader in depot injections and implants.  "Bharat is seeking potential business partners who offer complementary advantages for depot injection projects in Europe and the US," advises Dhiraj.

TCI's report also includes a market analysis of injectable depot technologies, sales of leading depot products in 2009, worldwide market growth from 2005-2009, market share by therapeutic category, role of generic chemicals and peptides, and product pipelines. Technology Catalysts forecasts the total parenteral depot market could approach nearly $8 billion by 2014.To download a complimentary excerpt of this report, go to: http://www.technology-catalysts.com/reports_services/depot.asp

About Technology Catalysts International:

Technology Catalysts International ("TCI") was founded in 1979 and provides consulting services in technology transfer and business research. The company specializes in technology licensing, technology assessment, and business intelligence. With a focus on pharmaceuticals, drug delivery, consumer healthcare, and advanced materials/processes, TCI's core consulting services are based on continuous monitoring of technological product development activities on a global basis.  TCI is headquartered in the US and has offices in the UK, Germany, Czech Republic, China, Korea, Japan, India, and Latin America.Contact:Ajay Rastogi, Vice PresidentTechnology Catalysts InternationalTelephone (703) 531-0257arastogi@technology-catalysts.comhttp://www.technology-catalysts.com
'/>"/>

SOURCE Technology Catalysts International
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Bioengineered veins offer new hope on horizon for patients lacking healthy veins for coronary bypass surgery or dialysis
2. Bionovo Announces Closing of Follow-on Offering of Common Stock and Warrants
3. Leading Scientific Laboratory Offers New Methods for Metals Testing
4. Spherix Announces Closing of Registered Direct Offering of $2.77 Million in Common Stock and Warrants
5. Ardea Biosciences Prices Public Offering of Common Stock
6. Investigational Compound Offers Novel Anti-IGF Approach To Inhibit Growth of Cancer Cells
7. Amarin Announces Proposed Public Offering of American Depositary Shares
8. Biotech Guru G. Steven Burrill Offers his Predictions on What Lies Ahead for the Biotech Industry in 2011
9. HRC Medical Center Offers Patients Relief with Innovative Bio-Identical Hormone Replacement Therapy
10. YM BioSciences Closes Public Offering of Common Shares
11. YM BIOSCIENCES PRICES $40 MILLION PUBLIC OFFERING
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 29, 2015 GeneWEAVE, Inc ... (MDROs), announced that initial feasibility data supporting the ... and susceptibility testing from positive blood cultures will ... 31, 2015 in New Orleans, LA. The Company’s ... diagnostics that can quickly detect bacteria and assess ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Market ... (Chem-Report ) signed a partnership agreement for quality ... authorised to distribute and sell research reports worked ... at Partners Department, commented upon the agreement: “Chem-Report ... on key petroleum and chemical markets on global ...
(Date:5/29/2015)... 2015  Caris Life Sciences® today announced the ... researchers utilized Caris Molecular Intelligence®, the company,s panomic, ... targets in patients with colorectal and pancreatic cancer ... death protein 1 (PD-1) and its ligand, PD-L1. ... 2015 American Society of Clinical Oncology Annual Meeting ...
(Date:5/29/2015)... Md. and RESEARCH TRIANGLE PARK, N.C. ... (NASDAQ: UTHR ) announced today that Roger Jeffs ... will provide an overview and update on the company,s business ... New York City . The presentation and ... June 4, 2015, at 11:00 AM Eastern Time, and can ...
Breaking Biology Technology:Data Highlighting GeneWEAVE’s Smarticles™ Technology to be Presented at the 115th General Meeting of the American Society for Microbiology (asm2015) 2Data Highlighting GeneWEAVE’s Smarticles™ Technology to be Presented at the 115th General Meeting of the American Society for Microbiology (asm2015) 3Market Publishers Ltd and Chem-Report Sign Partnership Agreement 2Market Publishers Ltd and Chem-Report Sign Partnership Agreement 3Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 2Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 3Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 4
... Raymond and Ruth Perelman School of Medicine at ... of a first-of-its-kind interdisciplinary center focused on discovering ... bring together, without institutional walls, all necessary approaches ... research support facilities, translating findings into therapies, fostering ...
...   Elsevier, the leading provider of scientific, ... to outstanding members of the wilderness medicine community at this ... Conference & Annual Meeting , taking place in Snowmass, CO, ... The aim of the Wilderness Medicine Society is to ...
... 2011 Selexis SA , a global life science ... scale-up to manufacturing of therapeutic proteins announced today that CSL ... Selexis for the preclinical development of a therapeutic antibody ... in 2012. This commercial license agreement provides CSL with the ...
Cached Biology Technology:Penn Receives $10 Million to Create Center for Orphan Disease Research and Therapy 2Elsevier Collaborates with the Wilderness Medicine Society to Award Outstanding Members 2Elsevier Collaborates with the Wilderness Medicine Society to Award Outstanding Members 3CSL Limited Signs Commercial License Agreement with Selexis SA 2
(Date:5/11/2015)... JOSE, Calif. , May 11, 2015 /PRNewswire/ ... developer of human interface solutions, today announced the ... Vice President and Chief Financial Officer, reporting to ... Ali replaces Synaptics, current Chief Financial Officer, ... December 2014. Mr. Ali brings ...
(Date:5/11/2015)... RYE, N.Y. , May 11, 2015 ... company, announced the start of a new Phase III ... effect of its novel formulation, CM-AT, on all children ... results of its FDA Phase III double blinded clinical ... who had low levels of the digestive enzyme chymotrypsin. ...
(Date:5/8/2015)... , May 8, 2015 Synaptics Inc. (NASDAQ: ... announced that members of the executive management team will present ... Annual Technology, Media and Telecom Conference Date: May 18, ... Boston, MA Cowen and ... Time: 2:45pm ET Location: The New York Palace Hotel, ...
Breaking Biology News(10 mins):Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2Synaptics to Present at Upcoming Investor Conferences 2
... The National Science Foundation (NSF) is funding a new ... high-achieving science and math undergraduates for teaching careers. ... within the College of Arts and Sciences at Case ... majors to become high school math and science teachers. ...
... Assistant Professor of Biomedical Engineering and Orthopedic Surgery has ... in Aging by The Ellison Medical Foundation. Case Western ... to submit a proposal, and Alsberg was one of ... National competition was strong, with only 25 awards being ...
... virulent avian influenza virus strain called H5N1 forms tiny tubules ... during viral infection, which otherwise would prompt an antiviral immune ... in an online report in the journal Nature . ... to form tiny tubules where double-stranded RNA is hidden from ...
Cached Biology News:NSF grant to launch undergrads from Case Western Reserve into math and science teaching 2NSF grant to launch undergrads from Case Western Reserve into math and science teaching 3Case Western Reserve receives Ellison Medical Foundation New Scholar in Aging award 2Protein 'tubules' free avian flu virus from immune recognition 2
...
... is a metabolically stable analog ... potent uterine stimulant and abortifacient ... to induce labor. It induces ... concentrations when given as an ...
... Biochem/physiol Actions: Glutathione-S-transferases (GSTs) are a group ... many xenobiotics in mammals. The enzymes ... thiol group of the glutathione to electrophilic ... mutagenic, carcinogenic, and toxic effects of the ...
... The National Instruments PCIe-1429 is the ... the NI PCIe-1429, you now can acquire ... bit depths available for Camera Link cameras ... synchronized data and image acquisition, fault analysis, ...
Biology Products: